Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Maravai LifeSciences Holdings Operating Margin % Related Terms
Maravai LifeSciences Holdings Operating Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:MAR vs ANRO, BBOT, REPL: Operating Margin % Comparison
For the Biotechnology subindustry, Maravai LifeSciences Holdings's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Maravai LifeSciences Holdings Operating Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Maravai LifeSciences Holdings's Operating Margin % distribution charts can be found below:
* The bar in red indicates where Maravai LifeSciences Holdings's Operating Margin % falls into.
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Maravai LifeSciences Holdings (STU:MAR) has a Operating Margin % of 1.09% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Maravai LifeSciences Holdings and its competitors. This is 93% below median its historical median of 15.51. According to the industry distribution chart, Maravai LifeSciences Holdings ranks #418 out of 945 companies in the Biotechnology industry, placing it in the top 44.2%.
Is Maravai LifeSciences Holdings' Operating Margin % too high?
Maravai LifeSciences Holdings' current Operating Margin % of 1.09% is 93% below median its 10-year median of 15.51. Based on the distribution chart, Maravai LifeSciences Holdings ranks #418 out of 945 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Maravai LifeSciences Holdings has a GF Score™ of 66/100, reflecting its overall financial health beyond just this single metric.
How does Maravai LifeSciences Holdings' Operating Margin % compare to ANRO and BBOT?
According to the Biotechnology industry distribution chart, Maravai LifeSciences Holdings ranks #418 out of 945 companies for Operating Margin %. This puts Maravai LifeSciences Holdings in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Biotechnology company?
A good Operating Margin % depends on the Biotechnology industry context. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Maravai LifeSciences Holdings and its competitors. Maravai LifeSciences Holdings's current Operating Margin % is 1.09%, which is 93% below median its own 10-year median of 15.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Maravai LifeSciences Holdings stock overvalued right now?
Maravai LifeSciences Holdings (STU:MAR) has a current Operating Margin % of 1.09%. The stock's GF Value™ is €3.33, compared to a current price of €4.68 — trading 40.5% above its estimated fair value. The current Operating Margin % is 1.09%, which is 93% below median its 10-year median of 15.51. Maravai LifeSciences Holdings' overall GF Score™ is 66/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Maravai LifeSciences Holdings (STU:MAR), the current Operating Margin % is 1.09% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Maravai LifeSciences Holdings (STU:MAR) Overvalued in 2026?
Based on GuruFocus' analysis, Maravai LifeSciences Holdings stock appears to be overvalued.
The current stock price of €4.68 is trading 40.5% above its estimated GF Value™ of €3.33.
Key valuation signals for STU:MAR:
Operating Margin %: 1.09% (93% below median its 10-year median of 15.51)
GF Value™: €3.33 vs. price of €4.68 (40.5% above fair value)
No single metric tells the full story. See the STU:MAR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Maravai LifeSciences Holdings Business Description
Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.
66GF Score
Get the complete analysis for STU:MAR
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:MAR has been successfully added to your 
